SOURCES:
Linda Geng, MD, PhD, assistant professor of medicine, Stanford University; co-director, Post-Acute COVID-19 Syndrome Center.
Diana Güthe, founder, COVID support group Survivor Corps.
Michael Peluso, MD, infectious diseases doctor, assistant professor of medicine, University of California, San Francisco.
Zachary Schwartz, MD, medical director, Post-COVID-19 Recovery Clinic, Vancouver General Hospital, Canada.
Alexander Truong, MD, pulmonologist, Emory University School of Medicine.
Monica Verduzco-Gutierrez, MD, physical medicine and rehabilitation doctor; director, post-COVID recovery program and clinic, San Antonio, TX.
Nature: “Promotion of non-evidence-based therapeutics within patient-led Long COVID support groups.”
Facebook: @COVID19survivorcorps, May 27, 2022.
Hormone and Metabolic Research: “Post COVID and Apheresis – Where are we Standing?”
The BMJ: “Long covid and apheresis: a miracle cure sold on a hypothesis of hope,” “Long covid patients travel abroad for expensive and experimental ‘blood washing.'”
FDA: “FDA Warns About Stem Cell Therapies,” “Dietary Supplements.”
Stem Cell Reports: “Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic.”
Cell Stem Cell: “The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.”
Scientific Reports: “Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.
